Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial

Elderly people are particularly vulnerable to COVID-19, with a high risk of developing severe disease and a reduced immune response to the COVID-19 vaccine. A randomized, placebo-controlled, double-blind trial to assess the effect of the consumption of the probiotic Loigolactobacillus coryniformis K...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Ferreiro, Anxo, Formigo-Couceiro, Francisco J., Veiga-Gutierrez, Roi, Maldonado-Lobón, Jose A., Hermida-Cao, Ana M., Rodriguez, Carlos, Bañuelos, Oscar, Olivares, Mónica, Blanco-Rojo, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747230/
https://www.ncbi.nlm.nih.gov/pubmed/35011103
http://dx.doi.org/10.3390/nu14010228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747230/
https://www.ncbi.nlm.nih.gov/pubmed/35011103
http://dx.doi.org/10.3390/nu14010228

Ejemplares similares